Vulnerability management, secure engineering, FDA-aligned documentation and security monitoring for connected devices running legacy firmware.
Services: Vulnerability & Patch Management | Secure Device Engineering | FDA Cybersecurity Documentation | Security Monitoring & Incident Response | Gap Assessment and Risk Stratification
Legacy firmware with unpatched CVEs, hard-coded credentials and unencrypted PHI transmission put both patient data and regulatory readiness at risk. EZEN Digital supported the remediation, the submission documentation and the monitoring that keeps the product secure after release.
Critical vulnerabilities eliminated
Within 90 days of deployment
Faster incident response
Compared with the pre-engagement baseline
FDA clearance, first submission
No resubmission reported
Connected medical devices running legacy firmware with unpatched CVEs, hard-coded credentials and unencrypted PHI transmission carry risk to patient data and to regulatory readiness. The product also showed non-conformance against FDA 510(k), IEC 62304, UL 2900-2-1 and AAMI TIR57 expectations.
EZEN Digital supported the work through SBOM-driven vulnerability and patch management, secure device and application engineering, regulatory compliance documentation, and real-time security monitoring and response. The reported results were 100% elimination of critical vulnerabilities within 90 days of deployment, 67% faster incident response against the pre-engagement baseline, and FDA 510(k) clearance on the first submission with no resubmission.
The gaps ran from the firmware and embedded applications to the vulnerability process, the data moving across device networks, and the documentation a submission depends on.
Legacy firmware and CVE exposure
Device and embedded application security
Vulnerability and patch management
Patient data protection
Regulatory documentation and readiness
Closing these gaps required engineering remediation, regulatory evidence and ongoing security operations to be planned together.
EZEN treated remediation, secure engineering, regulatory documentation and monitoring as one program rather than separate checks.
• SBOM creation, CVE tracking and controlled patch deployment
• Automated vulnerability scanning with Nessus, Qualys and Trivy
• Threat modeling, SAST/DAST and OWASP Top 10 validation
• Zero-trust network architecture and encrypted data flows
• HIPAA, GDPR, IEC 62304, UL 2900-2-1 and FDA premarket cybersecurity guidance
• Gap analysis, remediation roadmap and submission-ready documentation
• SIEM integration, continuous device telemetry and anomaly detection
• Incident response playbooks and forensic investigation capability
Critical vulnerabilities eliminated
Identified critical vulnerabilities were eliminated within 90 days of deployment.
Faster incident response
Incident response time improved by 67% compared with the pre-engagement baseline.
Supported FDA 510(k) submission
FDA 510(k) clearance was reported without resubmission.
EZEN treated remediation, secure engineering, regulatory documentation and monitoring as one program rather than separate checks.
Connected medical devices need cybersecurity controls that can be maintained across the product lifecycle, not only assessed before a regulatory submission. This work combined engineering remediation, vulnerability management, regulatory documentation and security operations in one program
Whether your team is addressing legacy firmware vulnerabilities, preparing cybersecurity evidence for a submission, or strengthening postmarket vulnerability management, EZEN can support the engineering and documentation work.